[FATE] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
03-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 81.02%
YoY- 83.89%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 1,676 1,944 933 58,980 44,356 14,981 18,549 -79.77%
PBT -44,122 -45,170 -52,755 -18,881 -56,363 -83,563 -76,105 -30.40%
Tax 18,832 -4,740 -4,381 -9,711 -8,056 -2,828 -757 -
NP -44,122 -45,170 -52,755 -9,170 -48,307 -80,735 -76,105 -30.40%
Tax Rate - - - - - - - -
Total Cost 45,798 47,114 53,688 68,150 92,663 95,716 94,654 -38.28%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -2,632.58 -2,323.56 -5,654.34 -15.55 -108.91 -538.92 -410.29 244.13%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.45 -0.46 -0.54 -0.09 -0.50 -0.83 -0.79 -31.21%
EPS Diluted -0.45 -0.46 -0.54 -0.09 -0.50 -0.83 -0.79 -31.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.